Benzinga's Top #PreMarket Losers

AcelRx Pharmaceuticals

shares slipped 10.71% to $6.00 in pre-market trading after the company offered a regulatory update for Zalviso. Finish Line

fell 8.19% to $27.00 in pre-market trading after the company reported downbeat second-quarter results. BlackBerry

shares dropped 2.55% to $9.55 in pre-market trading. The company reported a narrower-than-expected second-quarter loss. However, the company's revenue missed analysts' estimates. Philip Morris International

dropped 0.60% to $83.20 in pre-market trading. Analysts at Bank of America downgraded Philip Morris International from Buy to Neutral and lowered the target price to $87.